FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

PDUFA news from FierceBiotech

News

FDA, Big Pharma team up on drug research center

In all the hoopla over the new FDA funding-and-reform legislation last month, a key provision was Read more...

FDA, Big Pharma collaborate on genetic tests

Seven of the world's biggest drug makers are banding together to create a research consortium that will develop genetic tests that can identify patients vulnerable to dangerous adverse events. Under Read more...

House passes PDUFA: bill heads to Senate

The U.S. House of Representatives has passed a bill to renew the Prescription Drug User Fee Act (PDUFA), positioning it to be passed by the Senate and signed by the President before the Friday Read more...

ALSO NOTED: FDA approves MedPointe's SOMA; EntreMed secures $20M loan; and much more...

> The FDA has approved MedPointe's SOMA (carisoprodol) 250 mg as a new recommended dose for the relief of discomfort associated with acute, painful musculoskeletal conditions, such as backache. Read more...

Waiting game continues for biogenerics

The folks at BIO are breathing a sigh of relief over Congressman Henry Waxman's comment that new legislation on Read more...

Press Releases

STATEMENT: Pallone on FDA Revitalization Act

PALLONE STATEMENT ON FDA REVITALIZATION ACT Washington, D.C. --- U.S. Rep. Frank Pallone, Jr. (D-NJ), Chairman of the House Energy and Commerce Subcommittee on Health, gave the following statement Read more...

PRESS RELEASE: BIO Commends House for Approving PDUFA Reauthorization Package

BIO Commends House for Approving PDUFA Reauthorization Package Calls for Senate to Also Pass Legislation Before Deadline Expires WASHINGTON, D.C. (September 19, 2007) -- Biotechnology Industry Read more...

Get more PDUFA coverage at: